Effective measures for secondary prevention of glycogen<unk>  disease type 1 (GSD type 1) include blood glucose (BG) monitoring, prevent overtreatment, growth tracking as well as several system wise recommendations including general medical care, gastrointestinal or nutritional, hepatic and hepatic transplantation, nephrology, hematology, cardiovascular, surgery/anesthesia, and gynecological/obstetrical recommendations.
Glycogen storage disease type I secondary prevention
Glycogen storage disease type II secondary prevention
Glycogen storage disease type III secondary prevention
Glycogen storage disease type II primary prevention
Glycogen storage disease type III primary prevention
Glycogen storage disease type I primary prevention
Glycogen storage disease type II medical therapy
Glycogen storage disease type I medical therapy